CDK2-IN-41
CDK2-IN-41 (Compound 7a) is a CDK2 inhibitor that exerts anticancer activity by binding to CDK2, thereby inhibiting the cell cycle, inducing cytotoxicity, promoting ROS production, and triggering Apoptosis. CDK2-IN-41 exhibits an IC50 of 10 µM against acute myeloid leukemia (AML) HL-60 cells. It holds potential for research in AML-related cancer therapy.
For research use only. We do not sell to patients.
- Formula: C19H21N3S
- Molecular Weight:323.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CDK2 |
Chemical Information
-
Molecular Weight 323.46
-
Formula C19H21N3S
-
SMILES
N#CC1=C2C(CNCC2)=C(C=C1N3CCCCC3)C4=CC=CS4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)